Time-related improvement of survival in resectable gastric cancer: The role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotheraphy

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Grau, Juan J ^a   Palmero, Ramon ^a   Marmol, Maribel ^a   Domingo Domenech, Jose ^a   Monzo, Mariano ^a   Fuster, Jose ^a   Vidal, Oscar ^a   Fondevila, Constantino ^a   Garcia Valdecasas, Juan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MITOMYCIN C; TEGAFUR;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PARTIAL GASTRECTOMY; PROGNOSIS; RETROSPECTIVE STUDY; SPLENECTOMY; STOMACH CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; TIME; TOTAL STOMACH RESECTION; TREATMENT OUTCOME;

EID: 33748698258     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-53     Document Type: Article

References (26)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80:827-841.
2. Kelley JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003, 56:1-9.
3. Coleman MP, Gatta G, Verdecchia. A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F, EUROCARE Working Group: EUROCARE-3 summary. cancer survival in Europe at the end of the 20th century. Ann Oncol 2003, 14(Suppi 5):v128-v149.
4. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, EUROCARE Working Group: EUROCARE-3: survival of cancer patients diagnosed 1990-1994: results and commentary. Ann Oncol 2003, 14(Suppl 5):v61-v118.
5. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy. Cancer 2000, 88:921-932.
6. Jemal A, Tiwari RC, Murria T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer Society: Cancer Statistics, 2004. CA Cancer J Clin 2004, 54:8-29.
7. Dixon E, Vollmer CM Jr, Sahajpal A, Cattral M, Grant D, Doig C, Hemming A, Taylor B, Langer B, Greig P, Gallinger S: An aggressive approach leads to improved survival in patients with gallbladder cancer. A 12-year study at a North American Centers. Ann Surg, 2005, 241:385-394.
8. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P: Patient survival after D1 and D2 dissections for gastric cancer: long-term results of the MCR randomised surgical trial. Br J Cancer 1999, 79:1522-1530.
9. Bonenkamp JJ, Hermans J, Sasako M, Van de Velde CJH: Extended lymph node dissection for gastric cancer. N Engl J Med 1999, 340:908-914.
10. McCulloch P: Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980-1985. Br J Surg 1994, 81:417-420.
11. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA: Chemotherapy after surgery compared with surgery alone for adenocarcinorna of the stomach or gastroesophageal junction. N Engl J Med 2001, 345:725-730.
12. Sakamoto J: Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Cancer Chemother Pharmacol 2004, 54(Suppl 1):S25-31.
13. Grau JJ, Estape J, Fuster J, Filella X, Visa J, Teres J, Soler G, Albiol S, Garcia-Valdecasas JC, Grande L, et al.: Randomized trial of adjuvant chemotherapy with mitomycin C plus ftorafur versus mitomycin C alone in resected locally advanced gastric cancer. J Clin Oncol 1998, 16:1036-1039.
14. Grau JJ, Domingo-Domenech J, Morente V, Pera M, Garcia-Valdecasas JC, Fuster J, Bombi A, Mellado B, Albanell J, Gascon P: Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant Tegafur. Oncology 2004, 66:226-233.
15. Kajitani T: Japanese Research Society for the Study of Gastric Cancer.: The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981, 11:127-145.
16. American Joint Committee on Cancer AJCC Cancer Staging Manual. 5th edition. Edited by: Fleming ID, Cooper JS, Henson DE, et al (Eds). Philadelphia. Lippincott-Raven; 1997.
17. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observations on each patient. Br J Cancer 1976, 34:585-612.
18. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. Am Stat Assoc 1958, 53:457-463.
19. Peto R, Pike MC: Conservatism of the approximation sigma (0-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 1973, 29:279-286.
20. Sasako M, McCulloch P, Kinoshita T, Maruyama K: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995, 82:346-351.
21. Kikuchi S, Sakakibara Y, Sakuramoto S, Kobayashi N, Shimao H, Mieno H, Kato Y, Kadowaki K, Hiki Y, Kakita A. Recent results in the surgical treatment of gastric cancer accordngn to the Japanese and TNM classification. Anticancer Res 2001, 21:3589-3594.
22. McCulloch P, Nita M, Kazi H, Gama-Rodrigues J: Extended versus limited nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004:CD001964.
23. Grau JJ, Martin M, Fuster J, Pera M, Garcia-Valdecasas JC, Bombi JA, Bordas JM, Alcobendas F, Grande L, Estape J: Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer. J Surg Oncol 2003, 82:234-240.
24. Douglass HO Jr: Gastric cancer: Overview of current therapies. Sem Oncol 1985, 12(Suppl 4):57-62.
25. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F: Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from prospective multicenter study. Ann Surg 2005, 241:247-255.
26. Cunningham D, Allum VH, Stenning SP, Weeden S: Perioperative chemotherapy in operable gastric and lower oesophageall cancer. Final results of a randomised, controlled trial (the MAGIG trial, ISRCTN 93793971. Proc ASCO 2005. Abstr 4001